![](/img/cover-not-exists.png)
P-506 A comparison of gemcitabine in two doses for stage III or IV NSCLC: A multi-instutional phase II study
Kang, H., Kim, S., Ahn, J., Kim, J., Kim, K., Kim, Y., Jung, M., Ryu, J., Roh, Y., Kang, H.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80999-7
Date:
July, 2005
File:
PDF, 149 KB
english, 2005